References
- Croce M. V., Fejes M., Riera N., et al. Clinical importance of circulating immune complexes in human acute lymphoblastic leukemia. Cancer Immunol Immunother 1985; 20: 91–95
- Croce M. V., Pasqualini S., Segal-Eiras A. Circulating immune complexes in breast cancer patients. Medicina 1987; 47: 371–376
- Hubbard R., Aggio M., Lozzio B., et al. Correlation of CIC and disease status in patients with leukaemia. Clin Exp Immunol 1981; 43: 46–53
- Seth R., Seth P. Circulating immune complex and NK-cell activity in progressive breast cancer. Breast Cancer Res Treat 1984; 4: 54–55
- Salinas F. A., Wee K. H., Silver H. K. Clinical relevance of immune complexes, associated antigen and antibody in cancer. Contemp Top Immunobiol 1985; 15: 55–109
- Gupta R., Leitch A., Morton D. Detection of tumour associated antigen in eluales from protein A columns for ex vivo immunoad-sorption of plasma from melanoma patients by radioimmunoassay. Clin Exp Immunol 1983; 53: 589–599
- Segal-Eiras A., Croce M. V. HTLV-Ip24 antigen in circulating immune complexes associated with acute T-lymphoblastic leukemia. Haematologica 1991; 76: 438–442
- Croce M. V., Segal-Eiras A. Circulating immune complexes (CIC) and carcinoembryonic antigen (CEA) in patients with colorectal cancer. J Exp Clin Cancer Res 1992; 11: 223–230
- Slanciu L., Dumitrascu D., Radu D., et al. Non-specific tumoral markers in hepato-cellular carcinoma. Med Intern 1990; 28: 139–144
- Kirchheimer J. C., Kolbl H., Tatra G., et al. Relationship between plasma levels of components of the fibrinolytic system and acute-phase reactions in patients with uterine malignancies. Eur J Clin Invest 1990; 20: 79–84
- Stamatiadis A., Toumamdou M., Vyssoulis G., et al. Value of serum acute-phase reactant proteins and CEA in the preoperative staging of colorectal cancer. Cancer 1990; 65: 2055–2057
- Saito T., Kuwahara A., Shimoda K., et al. Factors influencing the acute phase protein levels in patients with esophageal cancer. Jpn JSurg 1991; 21: 402–411
- Bartoloni C., Guidi L., Baroni R., et al. Circulating immune complexes detected by a direct nephelometric assay and acute phase proteins in malignant tumors. Allergol Immunol (Paris) 1990; 2: 411–416
- Avail Lundqvist E., Blad E., Xiao L., et al. Prelreatment serum levels of C-reactive protein, α1-antitrypsin, haptoglobin, α1-acid glycoprotein and tissue polypeptide antigen in cervical carcinoma. Eur J Gynaecol Oncol 1991; 12: 375–383
- UICC: TNM classification of Malignant Tumours, 4th ed., P. Hermaned, L. H. Sobin. Springer-Verlag, Berlin 1987; 40–42
- AJCC Manual for Staging of Cancer, 3rd ed., O. H. Beahrs, D. E. Henson, R. VP Hutter, M. H. Myers. JB Lippincott, Philadelphia 1988; 63–65
- Zubler R., Lange G., Lambert P., et al. Detection of immune complexes in unheated sera by modified 125 I-Ciq binding test. J Immunol 1976; 116: 232–235
- Creighton W., Lambert P., Miescher D. Detection of antibodies and soluble antigen-antibody complexes by precipitation with polyethylenglicol. J Immunol 1973; 11: 1219–1227
- Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–685
- Towbin H., Staehlin T., Gordon J. Electrophoretic transfer of protein from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350–4354
- Poulton T., Mooney N., Nineham L., et al. Characteristics of immune complexes detectable by two independent assays in gynaecological malignancies. Clin Exp Immunol 1983; 53: 573–580
- Segal-Eiras A., Robins R. A., Baldwin R. W., et al. Circulating immune complexes in human bone tumours. Int J Cancer 1980; 25: 735–739
- Lowe J., Segal-Eiras A., Iles P., et al. Circulating immune complexes in patients with lung cancer. Thorax 1981; 36: 56–59
- Kolb-Bachofen V. A review on the biological properties of C-reactive protein. Immunobiology 1991; 183: 133–145
- Jiang H., Siegel J., Gewurz H. Binding and complement activation by C-reactive protein via the collagen-like region of C1q and inhibition of these reactions by monoclonal antibodies to C-reactive protein and C1q. J Immunol 1991; 146: 2324–2330
- Köttgen E., Hell B., Kage A., et al. Lectin specificity and binding characteristics of human C-reactive protein. J Immunol 1992; 149: 445–453
- Rudman D., Treadwell P., Vogler W. R., et al. An abnormal orosomu-coid in the plasma of patients with neoplastic disease. Cancer Res 1972; 32: 1951–1959
- Singhal A. K., Singhal M. C., Nudelman E., et al. Presence of fucolipid antigens with mono- and dimeric X determinant (Lex) in the CIC of patients with adenocarcinoma. Cancer Res 1987; 47: 5566–5571
- De Graaf T. W., Van der Stelt M. E., Anbergen M. G., et al. Inflammation-induced expression of sialyl Lewis x-containing glycan structures on α1-acid glycoprotein (orosomucoid) in human sera. J Exp Med 1993; 177: 657–666
- Durdey P., Looper J. C., Switala S., et al. The role of peptidases in cancer of the rectum and sigmoid colon. Br J Surg 1985; 72: 378–381